Hypotheses concerning the mechanism of action of antidepressant drugs.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects; D001921:Brain / Q000378:metabolism / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D004594:Electrophysiology; D006633:Histamine Antagonists / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000502:physiology; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D011954:Receptors, Dopamine / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists / Q000494:pharmacology
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D018492:Dopamine Antagonists; D006633:Histamine Antagonists; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011954:Receptors, Dopamine; D012702:Serotonin Antagonists; D012701:Serotonin; D000109:Acetylcholine; D007099:Imipramine; D004298:Dopamine; D009638:Norepinephrine